123 related articles for article (PubMed ID: 20150592)
41. Fluorescent ligands to investigate GPCR binding properties and oligomerization.
Cottet M; Faklaris O; Falco A; Trinquet E; Pin JP; Mouillac B; Durroux T
Biochem Soc Trans; 2013 Feb; 41(1):148-53. PubMed ID: 23356275
[TBL] [Abstract][Full Text] [Related]
42. Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Cofactor Recruitment Assay for PPARα and PPARγ.
Roth D; Benz J; Grether U; Dietz M
Methods Mol Biol; 2023; 2576():155-169. PubMed ID: 36152184
[TBL] [Abstract][Full Text] [Related]
43. Modulation of coactivator recruitment by cooperative ligand binding to human Estrogen receptor alpha and beta.
Suzuki S; Nishida S; Ohno K; Santa T
Biol Pharm Bull; 2007 Sep; 30(9):1641-7. PubMed ID: 17827713
[TBL] [Abstract][Full Text] [Related]
44. Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate.
Tamrazi A; Carlson KE; Daniels JR; Hurth KM; Katzenellenbogen JA
Mol Endocrinol; 2002 Dec; 16(12):2706-19. PubMed ID: 12456792
[TBL] [Abstract][Full Text] [Related]
45. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata H; Spencer TE; Oñate SA; Jenster G; Tsai SY; Tsai MJ; O'Malley BW
Recent Prog Horm Res; 1997; 52():141-64; discussion 164-5. PubMed ID: 9238851
[TBL] [Abstract][Full Text] [Related]
46. Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.
Tamrazi A; Carlson KE; Rodriguez AL; Katzenellenbogen JA
Mol Endocrinol; 2005 Jun; 19(6):1516-28. PubMed ID: 15661830
[TBL] [Abstract][Full Text] [Related]
47. Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor-alpha binding assay: protocol optimization and intralaboratory assay performance as initial steps towards validation.
Freyberger A; Wilson V; Weimer M; Tan S; Tran HS; Ahr HJ
Reprod Toxicol; 2010 Aug; 30(1):50-9. PubMed ID: 20074635
[TBL] [Abstract][Full Text] [Related]
48. Synthetic 19-nortestosterone derivatives as estrogen receptor alpha subtype-selective ligands induce similar receptor conformational changes and steroid receptor coactivator recruitment than natural estrogens.
García-Becerra R; Borja-Cacho E; Cooney AJ; Smith CL; Lemus AE; Pérez-Palacios G; Larrea F
J Steroid Biochem Mol Biol; 2006 May; 99(2-3):108-14. PubMed ID: 16616843
[TBL] [Abstract][Full Text] [Related]
49. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
[TBL] [Abstract][Full Text] [Related]
50. In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization.
Wang S; Zhang C; Nordeen SK; Shapiro DJ
J Biol Chem; 2007 Feb; 282(5):2765-75. PubMed ID: 17135255
[TBL] [Abstract][Full Text] [Related]
51. Ligand-induced coactivator recruitment to peroxisome proliferator-activated receptor alpha characterized by fluorescence resonance energy transfer.
Miao B; Sun S; Santomenna LD; Zhang JH; Young P; Mukherjee R
Methods Enzymol; 2002; 357():180-8. PubMed ID: 12424909
[No Abstract] [Full Text] [Related]
52. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
53. A quantitative high-throughput screen identifies novel inhibitors of the interaction of thyroid receptor beta with a peptide of steroid receptor coactivator 2.
Johnson RL; Hwang JY; Arnold LA; Huang R; Wichterman J; Augustinaite I; Austin CP; Inglese J; Guy RK; Huang W
J Biomol Screen; 2011 Jul; 16(6):618-27. PubMed ID: 21482722
[TBL] [Abstract][Full Text] [Related]
54. Simultaneous monitoring of discrete binding events using dual-acceptor terbium-based LRET.
Kupcho KR; Stafslien DK; DeRosier T; Hallis TM; Ozers MS; Vogel KW
J Am Chem Soc; 2007 Nov; 129(44):13372-3. PubMed ID: 17929812
[No Abstract] [Full Text] [Related]
55. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
[TBL] [Abstract][Full Text] [Related]
56. A universal homogeneous assay for high-throughput determination of binding kinetics.
Schiele F; Ayaz P; Fernández-Montalván A
Anal Biochem; 2015 Jan; 468():42-9. PubMed ID: 25240173
[TBL] [Abstract][Full Text] [Related]
57. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
58. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
[TBL] [Abstract][Full Text] [Related]
59. The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors.
Edwards DP
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):307-24. PubMed ID: 14973393
[TBL] [Abstract][Full Text] [Related]
60. Identification of d-seco modified steroid derivatives with affinity for estrogen receptor α and β isoforms using a non-transcriptional fluorescent cell assay in yeast.
Bekić SS; Marinović MA; Petri ET; Sakač MN; Nikolić AR; Kojić VV; Ćelić AS
Steroids; 2018 Feb; 130():22-30. PubMed ID: 29224741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
